A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors.

Fontana, Anna; Cursaro, Ilaria; Carullo, Gabriele; Gemma, Sandra; Butini, Stefania; Campiani, Giuseppe

Fontana, Anna; Cursaro, Ilaria; Carullo, Gabriele; Gemma, Sandra; Butini, Stefania; Campiani, Giuseppe.

Afiliación

Fontana A; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Cursaro I; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Carullo G; Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Gemma S; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Butini S; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Campiani G; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.

Int J Mol Sci ; 23(17)2022 Sep 02.

Article en En | MEDLINE | ID: mdl-36077415

Asunto(s)

Neoplasias; Proteínas Represoras; Inhibidores de Histona Desacetilasas/farmacología; Inhibidores de Histona Desacetilasas/uso terapéutico; Histona Desacetilasas/metabolismo; Humanos; Neoplasias/tratamiento farmacológico; Proteínas Represoras/genética; Proteínas Represoras/metabolismo

Palabras clave

HDAC8; HDAC8 inhibitor; cancer; fibrosis; histone deacetylase; polypharmacology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Represoras / Neoplasias Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google